Quick Answer
ABEONA THERAPEUTICS INC. reported Cash And Cash Equivalents At Carrying Value of $78.44 million for the year ending 2025.
- ABEONA THERAPEUTICS INC. showed an increase of +235.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from ABEONA THERAPEUTICS INC.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), ABEONA THERAPEUTICS INC.'s Cash And Cash Equivalents At Carrying Value has grown by 12,822.1%.
- Historical annual values: Fiscal year 2025: $78.44 million | Fiscal year 2024: $23.36 million | Fiscal year 2023: $14.47 million | Fiscal year 2022: $14.22 million | Fiscal year 2021: $32.94 million | Fiscal year 2020: $12.60 million | Fiscal year 2019: $129.26 million | Fiscal year 2018: $18.75 million | Fiscal year 2017: $137.75 million | Fiscal year 2016: $69.14 million | Fiscal year 2015: $40.14 million | Fiscal year 2014: $11.52 million | Fiscal year 2013: $424.0 thousand | Fiscal year 2012: $396.0 thousand | Fiscal year 2011: $2.46 million | Fiscal year 2010: $7.03 million | Fiscal year 2009: $607.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: